Xbrane Biopharma AB (XBRANE)

Stockholm
Currency in SEK
Disclaimer
82.90
+3.70
(+4.67%)
Closed
Day's Range
79.40
82.90
52 wk Range
55.60
107.80
Volume
19,072
Prev. Close
79.2
Open
79.5
Day's Range
79.4-82.9
52 wk Range
55.6-107.8
Volume
19,072
Average Vol. (3m)
35,219
1-Year Change
-20.29%
Shares Outstanding
27,506,018
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
136.50
Upside +64.66%

Xbrane Biopharma AB Analysis

Xbrane Biopharma AB Company Profile

Xbrane Biopharma AB, formerly Xbrane Bioscience AB, is a Sweden-based provider of biotechnology research and development services. It develops biogenerics for injectable slow release drugs and high-yield protein expression technology for the development of biosimilars. The Company's main products are Sperotide, a generic on the originator drug marketed under the trademarks Decapeptyl, Trelstar and Pamorelin, as well as Xlucane, a biosimilar on the originator drug sold under the trademark Lucentis.